8-Kfiled October 10, 2023, 7:59 PM ETticker TLPHCIK 0001427925
other materialconfidence highsentiment neutralmateriality 0.35
AcelRx shareholders approve 1.5M share increase to 2020 equity plan; elect three directors
TALPHERA, INC.
Shareholders approved amendment to increase shares under the 2020 Equity Incentive Plan by 1,500,000 (for: 6,562,640; against: 486,414; abstain: 35,579).
Three Class III directors elected: Marina Bozilenko (6,746,727 for), Howard B. Rosen (6,691,709 for), Mark Wan (6,724,271 for).
Advisory vote on named executive officer compensation passed with 6,543,669 for, 510,636 against, 30,328 abstain.
Proposal to ratify Withum as auditor withdrawn after Audit Committee dismissed Withum and engaged BPM LLP effective October 2, 2023.
Total shares represented at meeting: 7,084,633 out of 16,340,118 entitled to vote (43.4% turnout).
Extracted from this filing and checked against the source text.
Shareholder VotesSEC 8-K Item 5.07confidence 0.9
TALPHERA, INC. shareholders approved Approval of amendment and restatement of the Amended and Restated 2020 Equity Incentive Plan at the 2023-10-10 meeting.
Proposal
equity plan
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Proposal No. 4 The Company’s Amended and Restated 2020 Equity Incentive Plan was approved, by the following vote: For Against Abstain 6,562,640 486,414 35,579
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.